Enzyme Induction 1975
DOI: 10.1007/978-1-4615-8954-9_8
|View full text |Cite
|
Sign up to set email alerts
|

Induction of the Drug-Metabolizing Enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

1977
1977
2013
2013

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(19 citation statements)
references
References 199 publications
0
19
0
Order By: Relevance
“…Many Cyt P-450 monooxygenases involved in catabolic transformations in animals, microbes, and plants are induced by treatment with the corresponding oxygenase substrate (Parke, 1957;Benveniste et al, 1982;Sligar and Murray, 1986). Cyt P-450 monooxygenase systems in plants have also been induced by treatment with growth hormones, heavy metals, and other xenobiotics (Reichhart et al, 1980;Adele et al, 1981).…”
Section: Induction Of Camphor-6-exo-hydroxylasementioning
confidence: 99%
“…Many Cyt P-450 monooxygenases involved in catabolic transformations in animals, microbes, and plants are induced by treatment with the corresponding oxygenase substrate (Parke, 1957;Benveniste et al, 1982;Sligar and Murray, 1986). Cyt P-450 monooxygenase systems in plants have also been induced by treatment with growth hormones, heavy metals, and other xenobiotics (Reichhart et al, 1980;Adele et al, 1981).…”
Section: Induction Of Camphor-6-exo-hydroxylasementioning
confidence: 99%
“…Although the enzyme system responsible for glucuronide formation is inducible (Blaschke, Berk, Rodkey, Scharschmidt, Collison & Waggoner, 1974;Lecamwasam, 1975;Parke, 1975), animal studies indicate that the stimulation of hepatic microsomal enzymes by phenobarbitone is associated with changes in several other measures of liver function, each of which could theoretically result in enhancement of metabolic drug clearance. These include increased concentration in the hepatocyte of the Y organic anion-binding protein (Reyes, Levy, Gatmaitan & Arias, 1971), increased bile flow (Redinger & Small, 1973) and increased liver blood flow (Ohnaus, Thorgeirsson, Davies & Breckenridge, 1970;Branch, Shand, Wilkinson & Nies, 1974;Nies, Wilkinson, Rush, Strother & McDevitt, 1977).…”
Section: Pharmacokinetic Analysismentioning
confidence: 99%
“…Chronic administration of therapeutic agents such as barbiturates and phenytoin, or exposure to environmental contaminants such as DDT, lindane, certain food additives, may induce the activity of drug metabolizing enzymes in hepatic microsomes (Conney, 1967;Kuntzman, 1969;Parke, 1975). A large number of clinically important drug interactions have been attributed to this mechanism (Breckenridge, 1975;Hunter & Chasseaud, 1976).…”
Section: Introductionmentioning
confidence: 99%
“…That these enzyme activities were inducible suggested they would be of clinical importance in pharmacology and therapeutics [4][5][6][7]. A few laboratories also recognized that P450 enzymes participated in steroid and fatty acid hydroxylation in both adrenal cortex and liver [8,9].…”
Section: Introductionmentioning
confidence: 99%